Top Markets
#1 Nesa Nesa +864.82%
#2 Black Phoenix Black Phoenix +858.91%
#3 QuantixAI QuantixAI +102.94%
#4 MetaDAO MetaDAO +28.24%
#5 Ontology Gas Ontology Gas +27.39%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +19.59%
#7 Bedrock Bedrock +18.87%
#8 Humanity Humanity +16.18%
#9 peaq peaq +15.88%
#10 Stacks Stacks +14.40%
Coin of the day
Nesa Nesa
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Catalent, Inc. Catalent, Inc.

Catalent, Inc.

CTLT
Classifica tra le azioni #1925
Catalent, Inc., operating globally through its various subsidiaries,... Catalent, Inc., operating globally through its various subsidiaries, specializes in the development and production of comprehensive solutions for a wide array of products, including pharmaceutical drugs, protein-based biologics, advanced cell and gene therapies, and consumer health items. The company's operations are strategically divided into four key segments: Biologics; Softgel and Oral Technologies; Oral and Specialty Delivery; and Clinical Supply Services. The Softgel and Oral Technologies division focuses on the formulation, development, and manufacturing of soft capsules. These are utilized in a diverse range of client products, such as prescription medications, over-the-counter drugs, nutritional supplements, unit-dose cosmetics, and medicinal preparations for animal health. Within the Biologics segment, Catalent undertakes the creation of biologic cell lines, develops and manufactures both cell therapy and viral-based gene therapy, and handles the formulation and production of parenteral dose forms, including vials, prefilled syringes, and cartridges. This segment also provides essential analytical development and testing capabilities. The Oral and Specialty Delivery segment offers extensive formulation, development, and manufacturing expertise across various technologies. It provides integrated downstream solutions spanning clinical development and commercial supply. This segment also features a dedicated oral delivery solutions platform, encompassing preclinical screening, formulation, analytical development, and current good manufacturing practices (cGMP) services. Finally, the Clinical Supply Services segment delivers vital support for drug and biologic clinical trials. Its services include manufacturing, specialized packaging, secure storage, efficient distribution, and comprehensive inventory management. This segment also offers "FastChain," a demand-led clinical supply service. Catalent serves a broad client base, including pharmaceutical, biotechnology, and consumer health organizations, alongside companies in other healthcare sectors like animal health and medical devices, and even the cosmetics industry. The company was founded in 2007 and maintains its headquarters in Somerset, New Jersey.
Prezzo delle azioni
$63.48
Ultima sincronizzazione: 2024-12-17
Capitalizzazione di mercato
$11.52B
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Catalent, Inc. (CTLT)

Categoria

Healthcare
Rapporto P/B per Catalent, Inc. (CTLT)
Rapporto P/B al August 2026 TTM: 3.19
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Catalent, Inc., il rapporto P/B attuale (TTM) è 3.19. Alla fine del 2023, era pari a 1.69.
Storico del rapporto P/B per Catalent, Inc. da 2011 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
2026 (TTM) 3.19 13.05%
2024 2.82 66.58%
2023 1.69 -57.00%
2022 3.94 -15.12%
2021 4.64 22.49%
2020 3.79 -19.29%
2019 4.69 -7.21%
2018 5.06 -16.60%
2017 6.06 34.40%
2016 4.51 -18.65%
2015 5.55 -187.94%
2014 -6.31 10.44%
2013 -5.71 -14.61%
2012 -6.69 0.00%
2011 0.00 0.00%
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 5.5207 73.17%
IN